Musculoskeletal Clues That Precede ATTR Cardiomyopathy

Key Takeaways:

• Transthyretin deposits in tenosynovium and ligament as well as myocardium, so orthopedic disease can precede cardiac symptoms by years.
• Carpal tunnel syndrome is the best-characterized clue. In one cohort, its probability peaked 5 to 9 years before the cardiac diagnosis.
• None of these findings is a screening test on its own. Their value lies in clustering with cardiac features.

Transthyretin amyloid cardiomyopathy (ATTR-CM) specifically refers to a cardiac diagnosis, but the misfolded transthyretin (TTR) that stiffens the myocardium also deposits in other tissues as well, and in some cases, the affected non-cardiac tissue causes symptoms considerably earlier. The 2025 American College of Cardiology concise clinical guidance now names musculoskeletal manifestations, specifically bilateral carpal tunnel syndrome and spinal stenosis, among the features that should raise suspicion of ATTR-CM in a patient with heart failure.¹ This places the orthopedic history among the more informative and least consistently taken parts of the workup.

One protein, several tissues

The same misfolding process that produces cardiac amyloid also deposits in connective tissue. In a prospective series, tenosynovium excised at the time of carpal tunnel release was stained with Congo red and typed by mass spectrometry, confirming amyloid in the soft tissue of the wrist itself.³ Because the carpal tunnel is narrow and unforgiving of added bulk, deposition there becomes symptomatic at a volume which myocardium still tolerates silently. The musculoskeletal presentation is not a separate condition travelling alongside ATTR-CM; it is the same disease, surfacing where the tissue has less tolerance.

What the carpal tunnel evidence shows

In a cohort of 538 patients and mutation carriers at a single amyloidosis centre, compared against a published general-population cohort of 14.9 million, lifetime prevalence of carpal tunnel syndrome requiring decompression surgery was 20.3 percent among patients with ATTR and cardiac involvement, versus 4.1 percent in the general population. Where cardiac involvement was absent, prevalence matched the general population, and in light-chain amyloidosis no excess was seen. The excess was driven by men, and standardized incidence ratios were highest in the seventh and eighth decades of life. Most useful for timing: the probability of carpal tunnel syndrome was highest 5 to 9 years before the cardiac diagnosis. Carpal tunnel syndrome was also an independent risk factor for mortality in ATTR, irrespective of cardiac involvement.²

This describes how common decompression surgery is among patients already known to have ATTR. It is not the probability that a patient presenting with carpal tunnel syndrome has amyloidosis, which is far lower.

The prospective view is smaller but more directly relevant. Among 98 consecutive patients undergoing carpal tunnel release, restricted to men 50 years and older and women 60 years and older, tenosynovial biopsy detected amyloid in 10 patients, or 10.2 percent, of whom 7 had ATTR. Two of the 98 were found on subsequent evaluation to have cardiac involvement, and 3 were started on therapy. The distinction matters: roughly 1 in 10 had amyloid in the wrist, while about 2 percent had amyloid in the heart.³

Spinal stenosis and tendon rupture

Two further orthopedic findings recur in ATTR. Lumbar and cervical spinal stenosis and spontaneous biceps tendon rupture are both noted in expert consensus as relatively specific to ATTR among the extracardiac clues.⁴ Quantitative data for these two are thinner than for carpal tunnel syndrome, and they are best treated as supporting features of a pattern rather than as independently weighted signals.

Reading the pattern, not the sign

Carpal tunnel syndrome is common in the general population and markedly more common in women, whose age-matched background rate in this analysis was roughly three times that of men. The amyloid signal runs against that grain, appearing as an excess in older men: among men with wild-type disease, standardized incidence ratios rose from 11.3 in the seventh decade to 15.5 in the eighth. Age, sex, and bilaterality are therefore part of what makes the history informative, and none of these findings functions as a screening test in isolation.²

The practical step is to ask, and to note timing. Prior bilateral carpal tunnel release, surgery for spinal stenosis, or a spontaneous tendon rupture, in a patient now presenting with unexplained heart failure and increased wall thickness, is a cluster of symptoms requiring further investigation. The lead time is what makes the question worth asking: a release performed 7 years ago is not incidental history in a patient whose heart is now in question. To this point, hand and spine surgeons must also consider testing for misfolded TTR and ponder this diagnosis as they often meet the patients earlier in their disease course.